{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:37:05Z","timestamp":1761514625840,"version":"3.40.3"},"publisher-location":"Cham","reference-count":110,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030909192"},{"type":"electronic","value":"9783030909208"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/112_2020_20","type":"book-chapter","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T06:03:08Z","timestamp":1596866588000},"page":"105-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Transportome Malfunctions and the Hallmarks of Pancreatic Cancer"],"prefix":"10.1007","author":[{"given":"Qi","family":"Ling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Kalthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,9]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","volume":"53","author":"C Almoguera","year":"1988","unstructured":"Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549\u2013554","journal-title":"Cell"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/gutjnl-2017-314353","volume":"68","author":"L Arnes","year":"2018","unstructured":"Arnes L, Liu Z, Wang J, Maurer C, Sagalovskiy I, Sanchez-Martin M, Bommakanti N, Garofalo DC, Balderes DA, Sussel L et al (2018) Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma. Gut 68:499\u2013511","journal-title":"Gut"},{"key":"20_CR3","doi-asserted-by":"crossref","unstructured":"Awaji M, Singh RK (2019) Cancer-associated fibroblasts\u2019 functional heterogeneity in pancreatic ductal adenocarcinoma. Cancers (Basel) 11","DOI":"10.3390\/cancers11030290"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, Miller DK, Christ AN, Bruxner TJ, Quinn MC et al (2016) Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531:47\u201352","journal-title":"Nature"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.1073\/pnas.0601273103","volume":"103","author":"N Bardeesy","year":"2006","unstructured":"Bardeesy N, Aguirre AJ, Chu GC, Cheng KH, Lopez LV, Hezel AF, Feng B, Brennan C, Weissleder R, Mahmood U et al (2006) Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A 103:5947\u20135952","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"40924","DOI":"10.1074\/jbc.M112.405837","volume":"287","author":"I Bauer","year":"2012","unstructured":"Bauer I, Grozio A, Lasiglie D, Basile G, Sturla L, Magnone M, Sociali G, Soncini D, Caffa I, Poggi A et al (2012) The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. J Biol Chem 287:40924\u201340937","journal-title":"J Biol Chem"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"47681","DOI":"10.1074\/jbc.M409627200","volume":"279","author":"T Begenisich","year":"2004","unstructured":"Begenisich T, Nakamoto T, Ovitt CE, Nehrke K, Brugnara C, Alper SL, Melvin JE (2004) Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4. J Biol Chem 279:47681\u201347687","journal-title":"J Biol Chem"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1038\/onc.2010.156","volume":"29","author":"S Beilke","year":"2010","unstructured":"Beilke S, Oswald F, Genze F, Wirth T, Adler G, Wagner M (2010) The zinc-finger protein KCMF1 is overexpressed during pancreatic cancer development and downregulation of KCMF1 inhibits pancreatic cancer development in mice. Oncogene 29:4058\u20134067","journal-title":"Oncogene"},{"key":"20_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.humpath.2010.10.005","volume":"42","author":"F Bergmann","year":"2011","unstructured":"Bergmann F, Andrulis M, Hartwig W, Penzel R, Gaida MM, Herpel E, Schirmacher P, Mechtersheimer G (2011) Discovered on gastrointestinal stromal tumor 1 (DOG1) is expressed in pancreatic centroacinar cells and in solid-pseudopapillary neoplasms--novel evidence for a histogenetic relationship. Hum Pathol 42:817\u2013823","journal-title":"Hum Pathol"},{"key":"20_CR10","first-page":"191","volume":"13","author":"DJ Birnbaum","year":"2016","unstructured":"Birnbaum DJ, Bertucci F, Finetti P, Adelaide J, Giovannini M, Turrini O, Delpero JR, Raoul JL, Chaffanet M, Moutardier V et al (2016) Expression of genes with copy number alterations and survival of patients with pancreatic adenocarcinoma. Cancer Genomics Proteomics 13:191\u2013200","journal-title":"Cancer Genomics Proteomics"},{"key":"20_CR11","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s00424-016-1891-9","volume":"468","author":"B Bonito","year":"2016","unstructured":"Bonito B, Sauter DR, Schwab A, Djamgoz MB, Novak I (2016) KCa3.1 (IK) modulates pancreatic cancer cell migration, invasion and proliferation: anomalous effects on TRAM-34. Pflugers Arch 468:1865\u20131875","journal-title":"Pflugers Arch"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/MPA.0b013e3181a56ebf","volume":"38","author":"M Brevet","year":"2009","unstructured":"Brevet M, Fucks D, Chatelain D, Regimbeau JM, Delcenserie R, Sevestre H, Ouadid-Ahidouch H (2009) Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation. Pancreas 38:649\u2013654","journal-title":"Pancreas"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1038\/sj.emboj.7601246","volume":"25","author":"M Buchholz","year":"2006","unstructured":"Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, Gress TM, Ellenrieder V (2006) Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+\/calcineurin signaling pathway. EMBO J 25:3714\u20133724","journal-title":"EMBO J"},{"key":"20_CR200","unstructured":"Cancer Genome Atlas Research Network (2017) Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell 32:185\u2013203.e13"},{"key":"20_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neo.2014.12.003","volume":"17","author":"RA Cardone","year":"2015","unstructured":"Cardone RA, Greco MR, Zeeberg K, Zaccagnino A, Saccomano M, Bellizzi A, Bruns P, Menga M, Pilarsky C, Schwab A et al (2015) A novel NHE1-centered signaling cassette drives epidermal growth factor receptor-dependent pancreatic tumor metastasis and is a target for combination therapy. Neoplasia 17:155\u2013166","journal-title":"Neoplasia"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115\u2013132","journal-title":"CA Cancer J Clin"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1172\/JCI59227","volume":"122","author":"MA Collins","year":"2012","unstructured":"Collins MA, Bednar F, Zhang Y, Brisset JC, Galban S, Galban CJ, Rakshit S, Flannagan KS, Adsay NV, Pasca di Magliano M (2012) Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest 122:639\u2013653","journal-title":"J Clin Invest"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, Cooc J, Weinkle J, Kim GE, Jakkula L et al (2011) Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med 17:500\u2013503","journal-title":"Nat Med"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","volume":"16","author":"EA Collisson","year":"2019","unstructured":"Collisson EA, Bailey P, Chang DK, Biankin AV (2019) Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol 16:207\u2013220","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1001\/jamaoncol.2016.3916","volume":"3","author":"AA Connor","year":"2017","unstructured":"Connor AA, Denroche RE, Jang GH, Timms L, Kalimuthu SN, Selander I, McPherson T, Wilson GW, Chan-Seng-Yue MA, Borozan I et al (2017) Association of distinct mutational signatures with correlates of increased immune activity in pancreatic ductal adenocarcinoma. JAMA Oncol 3:774\u2013783","journal-title":"JAMA Oncol"},{"key":"20_CR21","doi-asserted-by":"publisher","first-page":"E4410","DOI":"10.1073\/pnas.1501605112","volume":"112","author":"A Daemen","year":"2015","unstructured":"Daemen A, Peterson D, Sahu N, McCord R, Du X, Liu B, Kowanetz K, Hong R, Moffat J, Gao M et al (2015) Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors. Proc Natl Acad Sci U S A 112:E4410\u2013E4417","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR22","doi-asserted-by":"publisher","first-page":"C1493","DOI":"10.1152\/ajpcell.00242.2010","volume":"299","author":"H Dong","year":"2010","unstructured":"Dong H, Shim KN, Li JM, Estrema C, Ornelas TA, Nguyen F, Liu S, Ramamoorthy SL, Ho S, Carethers JM et al (2010) Molecular mechanisms underlying Ca2+-mediated motility of human pancreatic duct cells. Am J Physiol Cell Physiol 299:C1493\u2013C1503","journal-title":"Am J Physiol Cell Physiol"},{"key":"20_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/CBM-181420","volume":"23","author":"D Dou","year":"2018","unstructured":"Dou D, Yang S, Lin Y, Zhang J (2018) An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma. Cancer Biomark 23:79\u201393","journal-title":"Cancer Biomark"},{"key":"20_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1096\/fj.201700480r","volume":"32","author":"TH Dovmark","year":"2018","unstructured":"Dovmark TH, Hulikova A, Niederer SA, Vaughan-Jones RD, Swietach P (2018) Normoxic cells remotely regulate the acid-base balance of cells at the hypoxic core of connexin-coupled tumor growths. FASEB J 32:83\u201396","journal-title":"FASEB J"},{"key":"20_CR25","first-page":"102675","volume":"53","author":"J Earl","year":"2020","unstructured":"Earl J, Galindo-Pumarino C, Encinas J, Barreto E, Castillo ME, Pachon V, Ferreiro R, Rodriguez-Garrote M, Gonzalez-Martinez S, Ramon YCT et al (2020) A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants. EBio Med 53:102675","journal-title":"EBio Med"},{"key":"20_CR26","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.18632\/oncotarget.2200","volume":"5","author":"J Feng","year":"2014","unstructured":"Feng J, Yu J, Pan X, Li Z, Chen Z, Zhang W, Wang B, Yang L, Xu H, Zhang G et al (2014) HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96. Oncotarget 5:5832\u20135844","journal-title":"Oncotarget"},{"key":"20_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/path.5154","volume":"246","author":"CG Fischer","year":"2018","unstructured":"Fischer CG, Wood LD (2018) From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions. J Pathol 246:395\u2013404","journal-title":"J Pathol"},{"key":"20_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fonc.2019.00115","volume":"9","author":"L Follia","year":"2019","unstructured":"Follia L, Ferrero G, Mandili G, Beccuti M, Giordano D, Spadi R, Satolli MA, Evangelista A, Katayama H, Hong W et al (2019) Integrative analysis of novel metabolic subtypes in pancreatic cancer fosters new prognostic biomarkers. Front Oncol 9:115","journal-title":"Front Oncol"},{"key":"20_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s10637-017-0438-z","volume":"35","author":"S Fu","year":"2017","unstructured":"Fu S, Hirte H, Welch S, Ilenchuk TT, Lutes T, Rice C, Fields N, Nemet A, Dugourd D, Piha-Paul S et al (2017) First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors. Investig New Drugs 35:324\u2013333","journal-title":"Investig New Drugs"},{"key":"20_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-015-0472-4","volume":"14","author":"A Giannuzzo","year":"2015","unstructured":"Giannuzzo A, Pedersen SF, Novak I (2015) The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells. Mol Cancer 14:203","journal-title":"Mol Cancer"},{"key":"20_CR31","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/ijc.30380","volume":"139","author":"A Giannuzzo","year":"2016","unstructured":"Giannuzzo A, Saccomano M, Napp J, Ellegaard M, Alves F, Novak I (2016) Targeting of the P2X7 receptor in pancreatic cancer and stellate cells. Int J Cancer 139:2540\u20132552","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"20_CR32","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1752-0509-8-S1-S3","volume":"8","author":"H Gong","year":"2014","unstructured":"Gong H, Wu TT, Clarke EM (2014) Pathway-gene identification for pancreatic cancer survival via doubly regularized cox regression. BMC Syst Biol 8(Suppl 1):S3","journal-title":"BMC Syst Biol"},{"key":"20_CR33","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1126\/science.271.5247.350","volume":"271","author":"SA Hahn","year":"1996","unstructured":"Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH et al (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350\u2013353","journal-title":"Science"},{"key":"20_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57\u201370","journal-title":"Cell"},{"key":"20_CR35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"20_CR36","doi-asserted-by":"publisher","first-page":"C151","DOI":"10.1152\/ajpcell.00089.2012","volume":"303","author":"M Hayashi","year":"2012","unstructured":"Hayashi M, Wang J, Hede SE, Novak I (2012) An intermediate-conductance Ca2+\u2212activated K+ channel is important for secretion in pancreatic duct cells. Am J Physiol Cell Physiol 303:C151\u2013C159","journal-title":"Am J Physiol Cell Physiol"},{"key":"20_CR37","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/ijc.28736","volume":"135","author":"O Helm","year":"2014","unstructured":"Helm O, Held-Feindt J, Grage-Griebenow E, Reiling N, Ungefroren H, Vogel I, Kruger U, Becker T, Ebsen M, Rocken C et al (2014) Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis. Int J Cancer 135:843\u2013861","journal-title":"Int J Cancer"},{"key":"20_CR38","first-page":"1024614","volume":"2019","author":"A Hennig","year":"2019","unstructured":"Hennig A, Wolf L, Jahnke B, Polster H, Seidlitz T, Werner K, Aust DE, Hampe J, Distler M, Weitz J et al (2019) CFTR expression analysis for subtyping of human pancreatic cancer organoids. Stem Cells Int 2019:1024614","journal-title":"Stem Cells Int"},{"key":"20_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA et al (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4:437\u2013450","journal-title":"Cancer Cell"},{"key":"20_CR40","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","volume":"7","author":"SR Hingorani","year":"2005","unstructured":"Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, Rustgi AK, Chang S, Tuveson DA (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7:469\u2013483","journal-title":"Cancer Cell"},{"key":"20_CR41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4251\/wjgo.v8.i3.282","volume":"8","author":"Y Hou","year":"2016","unstructured":"Hou Y, Guan X, Yang Z, Li C (2016) Emerging role of cystic fibrosis transmembrane conductance regulator - an epithelial chloride channel in gastrointestinal cancers. World J Gastrointest Oncol 8:282\u2013288","journal-title":"World J Gastrointest Oncol"},{"key":"20_CR42","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1124\/mol.65.3.630","volume":"65","author":"H Jager","year":"2004","unstructured":"Jager H, Dreker T, Buck A, Giehl K, Gress T, Grissmer S (2004) Blockage of intermediate-conductance Ca2+\u2212activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 65:630\u2013638","journal-title":"Mol Pharmacol"},{"key":"20_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.bbrc.2017.10.072","volume":"494","author":"S Jiang","year":"2017","unstructured":"Jiang S, Zhu L, Yang J, Hu L, Gu J, Xing X, Sun Y, Zhang Z (2017) Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer. Biochem Biophys Res Commun 494:113\u2013119","journal-title":"Biochem Biophys Res Commun"},{"key":"20_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1389450118666170711151518","volume":"19","author":"D Kamel","year":"2018","unstructured":"Kamel D, Gray C, Walia JS, Kumar V (2018) PARP inhibitor drugs in the treatment of breast, ovarian, prostate and pancreatic cancers: an update of clinical trials. Curr Drug Targets 19:21\u201337","journal-title":"Curr Drug Targets"},{"key":"20_CR45","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.gastro.2011.12.042","volume":"142","author":"M Kanda","year":"2012","unstructured":"Kanda M, Matthaei H, Wu J, Hong SM, Yu J, Borges M, Hruban RH, Maitra A, Kinzler K, Vogelstein B et al (2012) Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology 142:730\u2013733.e739","journal-title":"Gastroenterology"},{"key":"20_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ijc.21257","volume":"118","author":"H Kayed","year":"2006","unstructured":"Kayed H, Kleeff J, Kolb A, Ketterer K, Keleg S, Felix K, Giese T, Penzel R, Zentgraf H, Buchler MW et al (2006) FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth. Int J Cancer 118:43\u201354","journal-title":"Int J Cancer"},{"key":"20_CR47","doi-asserted-by":"publisher","first-page":"6742","DOI":"10.18632\/oncotarget.14272","volume":"8","author":"AA Kendrick","year":"2017","unstructured":"Kendrick AA, Schafer J, Dzieciatkowska M, Nemkov T, D'Alessandro A, Neelakantan D, Ford HL, Pearson CG, Weekes CD, Hansen KC et al (2017) CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming. Oncotarget 8:6742\u20136762","journal-title":"Oncotarget"},{"issue":"Suppl 2","key":"20_CR48","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1475-925X-13-S2-S5","volume":"13","author":"S Kim","year":"2014","unstructured":"Kim S, Kang M, Lee S, Bae S, Han S, Jang JY, Park T (2014) Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer. Biomed Eng Online 13(Suppl 2):S5","journal-title":"Biomed Eng Online"},{"key":"20_CR49","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-17-0162","volume":"23","author":"ES Knudsen","year":"2017","unstructured":"Knudsen ES, Vail P, Balaji U, Ngo H, Botros IW, Makarov V, Riaz N, Balachandran V, Leach S, Thompson DM et al (2017) Stratification of pancreatic ductal adenocarcinoma: combinatorial genetic, stromal, and immunologic markers. Clin Cancer Res 23:4429\u20134440","journal-title":"Clin Cancer Res"},{"key":"20_CR50","doi-asserted-by":"publisher","first-page":"8121","DOI":"10.1158\/0008-5472.CAN-06-4167","volume":"67","author":"K Kojima","year":"2007","unstructured":"Kojima K, Vickers SM, Adsay NV, Jhala NC, Kim HG, Schoeb TR, Grizzle WE, Klug CA (2007) Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Cancer Res 67:8121\u20138130","journal-title":"Cancer Res"},{"key":"20_CR51","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.bbamcr.2014.02.012","volume":"1843","author":"K Kondratska","year":"2014","unstructured":"Kondratska K, Kondratskyi A, Yassine M, Lemonnier L, Lepage G, Morabito A, Skryma R, Prevarskaya N (2014) Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma. Biochim Biophys Acta 1843:2263\u20132269","journal-title":"Biochim Biophys Acta"},{"key":"20_CR52","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1139\/bcb-2014-0078","volume":"92","author":"SC Kong","year":"2014","unstructured":"Kong SC, Giannuzzo A, Novak I, Pedersen SF (2014) Acid-base transport in pancreatic cancer: molecular mechanisms and clinical potential. Biochem Cell Biol 92:449\u2013459","journal-title":"Biochem Cell Biol"},{"key":"20_CR53","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1097\/MPA.0000000000000571","volume":"45","author":"SC Kong","year":"2016","unstructured":"Kong SC, Nohr-Nielsen A, Zeeberg K, Reshkin SJ, Hoffmann EK, Novak I, Pedersen SF (2016) Monocarboxylate transporters MCT1 and MCT4 regulate migration and invasion of pancreatic ductal adenocarcinoma cells. Pancreas 45:1036\u20131047","journal-title":"Pancreas"},{"key":"20_CR54","doi-asserted-by":"publisher","first-page":"e0160658","DOI":"10.1371\/journal.pone.0160658","volume":"11","author":"I Kovalenko","year":"2016","unstructured":"Kovalenko I, Glasauer A, Schockel L, Sauter DR, Ehrmann A, Sohler F, Hagebarth A, Novak I, Christian S (2016) Identification of KCa3.1 channel as a novel regulator of oxidative phosphorylation in a subset of pancreatic carcinoma cell lines. PLoS One 11:e0160658","journal-title":"PLoS One"},{"key":"20_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-019-0966-6","volume":"18","author":"MB Lankadasari","year":"2019","unstructured":"Lankadasari MB, Mukhopadhyay P, Mohammed S, Harikumar KB (2019) TAMing pancreatic cancer: combat with a double edged sword. Mol Cancer 18:48","journal-title":"Mol Cancer"},{"key":"20_CR56","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/bjc.2015.28","volume":"112","author":"E Lastraioli","year":"2015","unstructured":"Lastraioli E, Perrone G, Sette A, Fiore A, Crociani O, Manoli S, D\u2019Amico M, Masselli M, Iorio J, Callea M et al (2015) hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma. Br J Cancer 112:1076\u20131087","journal-title":"Br J Cancer"},{"key":"20_CR57","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ccell.2017.03.003","volume":"31","author":"L Leanza","year":"2017","unstructured":"Leanza L, Romio M, Becker KA, Azzolini M, Trentin L, Manago A, Venturini E, Zaccagnino A, Mattarei A, Carraretto L et al (2017) Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo. Cancer Cell 31:516\u2013531.e510","journal-title":"Cancer Cell"},{"key":"20_CR58","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2019.05.012","volume":"178","author":"M Ligorio","year":"2019","unstructured":"Ligorio M, Sil S, Malagon-Lopez J, Nieman LT, Misale S, Di Pilato M, Ebright RY, Karabacak MN, Kulkarni AS, Liu A et al (2019) Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer. Cell 178:160\u2013175.e127","journal-title":"Cell"},{"key":"20_CR59","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.3748\/wjg.v21.i26.7988","volume":"21","author":"QJ Lin","year":"2015","unstructured":"Lin QJ, Yang F, Jin C, Fu DL (2015) Current status and progress of pancreatic cancer in China. World J Gastroenterol 21:7988\u20138003","journal-title":"World J Gastroenterol"},{"key":"20_CR60","first-page":"7537","volume":"17","author":"R Lin","year":"2018","unstructured":"Lin R, Wang Y, Chen Q, Liu Z, Xiao S, Wang B, Shi B (2018) TRPM2 promotes the proliferation and invasion of pancreatic ductal adenocarcinoma. Mol Med Rep 17:7537\u20137544","journal-title":"Mol Med Rep"},{"key":"20_CR61","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.pan.2018.08.011","volume":"18","author":"J Liu","year":"2018","unstructured":"Liu J, Hu G, Gong Y, Yu Q, He B, Li W, He Z, Hao W, Liu Y (2018) Silencing of TRPM8 inhibits aggressive tumor phenotypes and enhances gemcitabine sensitivity in pancreatic cancer. Pancreatology 18:935\u2013944","journal-title":"Pancreatology"},{"key":"20_CR62","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.7314\/APJCP.2015.16.6.2489","volume":"16","author":"J Long","year":"2015","unstructured":"Long J, Zhang ZB, Liu Z, Xu YH, Ge CL (2015) Loss of heterozygosity at the calcium regulation gene locus on chromosome 10q in human pancreatic cancer. Asian Pac J Cancer Prev 16:2489\u20132493","journal-title":"Asian Pac J Cancer Prev"},{"key":"20_CR63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/MPA.0000000000001230","volume":"48","author":"G Luo","year":"2019","unstructured":"Luo G, Zhang Y, Guo P, Ji H, Xiao Y, Li K (2019) Global patterns and trends in pancreatic cancer incidence: age, period, and birth cohort analysis. Pancreas 48:199\u2013208","journal-title":"Pancreas"},{"key":"20_CR64","doi-asserted-by":"publisher","first-page":"27776","DOI":"10.1074\/jbc.M503150200","volume":"280","author":"YA Mahmmoud","year":"2005","unstructured":"Mahmmoud YA, Vorum H, Cornelius F (2005) Interaction of FXYD10 (PLMS) with Na,K-ATPase from shark rectal glands. Close proximity of Cys74 of FXYD10 to Cys254 in the a domain of the alpha-subunit revealed by intermolecular thiol cross-linking. J Biol Chem 280:27776\u201327782","journal-title":"J Biol Chem"},{"key":"20_CR65","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.lpm.2019.02.030","volume":"48","author":"P Maisonneuve","year":"2019","unstructured":"Maisonneuve P (2019) Epidemiology and burden of pancreatic cancer. Presse Med 48:e113\u2013e123","journal-title":"Presse Med"},{"key":"20_CR66","doi-asserted-by":"crossref","unstructured":"Manoli S, Coppola S, Duranti C, Lulli M, Magni L, Kuppalu N, Nielsen N, Schmidt T, Schwab A, Becchetti A et al (2019) The activity of Kv 11.1 potassium channel modulates F-actin organization during cell migration of pancreatic ductal adenocarcinoma cells. Cancers (Basel) 11","DOI":"10.3390\/cancers11020135"},{"key":"20_CR67","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/annonc\/mdz181","volume":"30","author":"S Martens","year":"2019","unstructured":"Martens S, Lefesvre P, Nicolle R, Biankin AV, Puleo F, Van Laethem JL, Rooman I (2019) Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications. Ann Oncol 30:1428\u20131436","journal-title":"Ann Oncol"},{"key":"20_CR68","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S0140-6736(16)00577-8","volume":"388","author":"M Maruthappu","year":"2016","unstructured":"Maruthappu M, Watkins J, Noor AM, Williams C, Ali R, Sullivan R, Zeltner T, Atun R (2016) Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990-2010: a longitudinal analysis. Lancet 388:684\u2013695","journal-title":"Lancet"},{"key":"20_CR69","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fonc.2018.00122","volume":"8","author":"A Mattarei","year":"2018","unstructured":"Mattarei A, Romio M, Manago A, Zoratti M, Paradisi C, Szabo I, Leanza L, Biasutto L (2018) Novel mitochondria-targeted furocoumarin derivatives as possible anti-cancer agents. Front Oncol 8:122","journal-title":"Front Oncol"},{"key":"20_CR70","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/gutjnl-2016-312432","volume":"67","author":"J Mayerle","year":"2018","unstructured":"Mayerle J, Kalthoff H, Reszka R, Kamlage B, Peter E, Schniewind B, Gonzalez Maldonado S, Pilarsky C, Heidecke CD, Schatz P et al (2018) Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut 67:128\u2013137","journal-title":"Gut"},{"key":"20_CR71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ceca.2019.03.002","volume":"80","author":"BA Miller","year":"2019","unstructured":"Miller BA (2019) TRPM2 in cancer. Cell Calcium 80:8\u201317","journal-title":"Cell Calcium"},{"key":"20_CR72","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt RA, Marayati R, Flate EL, Volmar KE, Loeza SG, Hoadley KA, Rashid NU, Williams LA, Eaton SC, Chung AH et al (2015) Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet 47:1168\u20131178","journal-title":"Nat Genet"},{"key":"20_CR73","first-page":"2140","volume":"57","author":"CA Moskaluk","year":"1997","unstructured":"Moskaluk CA, Hruban RH, Kern SE (1997) p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 57:2140\u20132143","journal-title":"Cancer Res"},{"key":"20_CR74","doi-asserted-by":"crossref","unstructured":"Pedersen SF, Novak I, Alves F, Schwab A, Pardo LA (2017) Alternating pH landscapes shape epithelial cancer initiation and progression: focus on pancreatic cancer. BioEssays 39","DOI":"10.1002\/bies.201600253"},{"key":"20_CR75","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1080\/15384101.2015.1078032","volume":"14","author":"S Peppicelli","year":"2015","unstructured":"Peppicelli S, Bianchini F, Toti A, Laurenzana A, Fibbi G, Calorini L (2015) Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression. Cell Cycle 14:3088\u20133100","journal-title":"Cell Cycle"},{"key":"20_CR76","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fonc.2017.00239","volume":"7","author":"R Peruzzo","year":"2017","unstructured":"Peruzzo R, Mattarei A, Romio M, Paradisi C, Zoratti M, Szabo I, Leanza L (2017) Regulation of proliferation by a mitochondrial potassium channel in pancreatic ductal adenocarcinoma cells. Front Oncol 7:239","journal-title":"Front Oncol"},{"key":"20_CR77","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2018.08.033","volume":"155","author":"F Puleo","year":"2018","unstructured":"Puleo F, Nicolle R, Blum Y, Cros J, Marisa L, Demetter P, Quertinmont E, Svrcek M, Elarouci N, Iovanna J et al (2018) Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features. Gastroenterology 155:1999\u20132013.e1993","journal-title":"Gastroenterology"},{"key":"20_CR78","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","volume":"32","author":"BJ Raphael","year":"2017","unstructured":"Raphael BJ et al (2017) Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell 32:185\u2013203.e113","journal-title":"Cancer Cell"},{"key":"20_CR79","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/S1542-3565(04)00450-1","volume":"2","author":"RP Reddy","year":"2004","unstructured":"Reddy RP, Smyrk TC, Zapiach M, Levy MJ, Pearson RK, Clain JE, Farnell MB, Sarr MG, Chari ST (2004) Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol 2:1026\u20131031","journal-title":"Clin Gastroenterol Hepatol"},{"key":"20_CR80","first-page":"3025","volume":"54","author":"MS Redston","year":"1994","unstructured":"Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, Kern SE (1994) p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 54:3025\u20133033","journal-title":"Cancer Res"},{"key":"20_CR81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajpath.2018.10.004","volume":"189","author":"B Ren","year":"2019","unstructured":"Ren B, Liu X, Suriawinata AA (2019) Pancreatic ductal adenocarcinoma and its precursor lesions: histopathology, cytopathology, and molecular pathology. Am J Pathol 189:9\u201321","journal-title":"Am J Pathol"},{"key":"20_CR82","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/1097-4652(200101)186:1<53::AID-JCP1004>3.0.CO;2-Q","volume":"186","author":"NM Ryder","year":"2001","unstructured":"Ryder NM, Guha S, Hines OJ, Reber HA, Rozengurt E (2001) G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation. J Cell Physiol 186:53\u201364","journal-title":"J Cell Physiol"},{"key":"20_CR83","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1158\/0008-5472.CAN-17-3061","volume":"78","author":"MC Sallan","year":"2018","unstructured":"Sallan MC, Visa A, Shaikh S, Nager M, Herreros J, Canti C (2018) T-type Ca(2+) channels: T for targetable. Cancer Res 78:603\u2013609","journal-title":"Cancer Res"},{"key":"20_CR84","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00424-014-1598-8","volume":"467","author":"DRP Sauter","year":"2015","unstructured":"Sauter DRP, Novak I, Pedersen SF, Larsen EH, Hoffmann EK (2015) ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC). Pflugers Arch 467:1495\u20131508","journal-title":"Pflugers Arch"},{"key":"20_CR85","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.bbadis.2016.07.009","volume":"1862","author":"DR Sauter","year":"2016","unstructured":"Sauter DR, Sorensen CE, Rapedius M, Bruggemann A, Novak I (2016) pH-sensitive K(+) channel TREK-1 is a novel target in pancreatic cancer. Biochim Biophys Acta 1862:1994\u20132003","journal-title":"Biochim Biophys Acta"},{"key":"20_CR86","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.trecan.2019.01.001","volume":"5","author":"J Schnittert","year":"2019","unstructured":"Schnittert J, Bansal R, Prakash J (2019) Targeting pancreatic stellate cells in cancer. Trends Cancer 5:128\u2013142","journal-title":"Trends Cancer"},{"key":"20_CR87","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","volume":"42","author":"A Sica","year":"2006","unstructured":"Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717\u2013727","journal-title":"Eur J Cancer"},{"key":"20_CR88","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1053\/j.gastro.2019.02.037","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi AD, George B, Greenbowe JR, Chung J, Suh J, Maitra A, Klempner SJ, Hendifar A, Milind JM, Golan T et al (2019a) Real-time targeted genome profile analysis of pancreatic ductal adenocarcinomas identifies genetic alterations that might be targeted with existing drugs or used as biomarkers. Gastroenterology 156:2242\u20132253.e2244","journal-title":"Gastroenterology"},{"key":"20_CR89","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1053\/j.gastro.2019.10.028","volume":"158","author":"AD Singhi","year":"2019","unstructured":"Singhi AD, Wood LD, Parks E, Torbenson MS, Felsenstein M, Hruban RH, Nikiforova MN, Wald AI, Kaya C, Nikiforov YE et al (2019b) Recurrent rearrangements in PRKACA and PRKACB in intraductal oncocytic papillary neoplasms of the pancreas and bile duct. Gastroenterology 158:573\u2013582","journal-title":"Gastroenterology"},{"key":"20_CR90","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.semcancer.2016.12.001","volume":"43","author":"C Stock","year":"2017","unstructured":"Stock C, Pedersen SF (2017) Roles of pH and the Na(+)\/H(+) exchanger NHE1 in cancer: from cell biology and animal models to an emerging translational perspective? Semin Cancer Biol 43:5\u201316","journal-title":"Semin Cancer Biol"},{"key":"20_CR91","doi-asserted-by":"publisher","first-page":"769","DOI":"10.18632\/oncotarget.13647","volume":"8","author":"H Storck","year":"2017","unstructured":"Storck H, Hild B, Schimmelpfennig S, Sargin S, Nielsen N, Zaccagnino A, Budde T, Novak I, Kalthoff H, Schwab A (2017) Ion channels in control of pancreatic stellate cell migration. Oncotarget 8:769\u2013784","journal-title":"Oncotarget"},{"key":"20_CR92","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.canlet.2016.04.027","volume":"377","author":"B Tang","year":"2016","unstructured":"Tang B, Chow JY, Dong TX, Yang SM, Lu DS, Carethers JM, Dong H (2016) Calcium sensing receptor suppresses human pancreatic tumorigenesis through a novel NCX1\/Ca(2+)\/beta-catenin signaling pathway. Cancer Lett 377:44\u201354","journal-title":"Cancer Lett"},{"key":"20_CR93","first-page":"1835","volume":"60","author":"T Ueki","year":"2000","unstructured":"Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH, Goggins M (2000) Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 60:1835\u20131839","journal-title":"Cancer Res"},{"key":"20_CR94","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev.biochem.75.103004.142819","volume":"76","author":"K Venkatachalam","year":"2007","unstructured":"Venkatachalam K, Montell C (2007) TRP channels. Annu Rev Biochem 76:387\u2013417","journal-title":"Annu Rev Biochem"},{"key":"20_CR95","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K et al (2015) Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518:495\u2013501","journal-title":"Nature"},{"key":"20_CR96","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1158\/1078-0432.CCR-17-3401","volume":"24","author":"M Wartenberg","year":"2018","unstructured":"Wartenberg M, Cibin S, Zlobec I, Vassella E, Eppenberger-Castori S, Terracciano L, Eichmann MD, Worni M, Gloor B, Perren A et al (2018) Integrated genomic and immunophenotypic classification of pancreatic cancer reveals three distinct subtypes with prognostic\/predictive significance. Clin Cancer Res 24:4444\u20134454","journal-title":"Clin Cancer Res"},{"key":"20_CR97","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1053\/j.gastro.2018.12.044","volume":"156","author":"MC Whittle","year":"2019","unstructured":"Whittle MC, Hingorani SR (2019) Fibroblasts in pancreatic ductal adenocarcinoma: biological mechanisms and therapeutic targets. Gastroenterology 156:2085\u20132096","journal-title":"Gastroenterology"},{"key":"20_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074589","volume":"8","author":"S Williams","year":"2013","unstructured":"Williams S, Bateman A, O'Kelly I (2013) Altered expression of two-pore domain potassium (K2P) channels in cancer. PLoS One 8:e74589","journal-title":"PLoS One"},{"key":"20_CR99","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2010.04.023","volume":"297","author":"NS Yee","year":"2010","unstructured":"Yee NS, Zhou W, Lee M (2010) Transient receptor potential channel TRPM8 is over-expressed and required for cellular proliferation in pancreatic adenocarcinoma. Cancer Lett 297:49\u201355","journal-title":"Cancer Lett"},{"key":"20_CR100","first-page":"415158","volume":"2012","author":"NS Yee","year":"2012","unstructured":"Yee NS, Chan AS, Yee JD, Yee RK (2012a) TRPM7 and TRPM8 ion channels in pancreatic adenocarcinoma: potential roles as cancer biomarkers and targets. Scientifica (Cairo) 2012:415158","journal-title":"Scientifica (Cairo)"},{"key":"20_CR101","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.canlet.2011.12.007","volume":"318","author":"NS Yee","year":"2012","unstructured":"Yee NS, Zhou W, Lee M, Yee RK (2012b) Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma. Cancer Lett 318:99\u2013105","journal-title":"Cancer Lett"},{"key":"20_CR102","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3390\/cells3020500","volume":"3","author":"NS Yee","year":"2014","unstructured":"Yee NS, Li Q, Kazi AA, Yang Z, Berg A, Yee RK (2014) Aberrantly over-expressed TRPM8 channels in pancreatic adenocarcinoma: correlation with tumor size\/stage and requirement for cancer cells invasion. Cell 3:500\u2013516","journal-title":"Cell"},{"key":"20_CR103","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrc.2010.09.036","volume":"401","author":"SH Young","year":"2010","unstructured":"Young SH, Rozengurt E (2010) Crosstalk between insulin receptor and G protein-coupled receptor signaling systems leads to Ca(2)+ oscillations in pancreatic cancer PANC-1 cells. Biochem Biophys Res Commun 401:154\u2013158","journal-title":"Biochem Biophys Res Commun"},{"key":"20_CR104","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00249-016-1171-9","volume":"45","author":"A Zaccagnino","year":"2016","unstructured":"Zaccagnino A, Pilarsky C, Tawfik D, Sebens S, Trauzold A, Novak I, Schwab A, Kalthoff H (2016) In silico analysis of the transportome in human pancreatic ductal adenocarcinoma. Eur Biophys J 45:749\u2013763","journal-title":"Eur Biophys J"},{"key":"20_CR105","doi-asserted-by":"publisher","first-page":"38276","DOI":"10.18632\/oncotarget.11299","volume":"8","author":"A Zaccagnino","year":"2017","unstructured":"Zaccagnino A, Manago A, Leanza L, Gontarewitz A, Linder B, Azzolini M, Biasutto L, Zoratti M, Peruzzo R, Legler K et al (2017) Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma. Oncotarget 8:38276\u201338293","journal-title":"Oncotarget"},{"key":"20_CR106","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/MPA.0000000000001136","volume":"47","author":"W Zhan","year":"2018","unstructured":"Zhan W, Shelton CA, Greer PJ, Brand RE, Whitcomb DC (2018) Germline variants and risk for pancreatic cancer: a systematic review and emerging concepts. Pancreas 47:924\u2013936","journal-title":"Pancreas"},{"key":"20_CR107","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1186\/s12885-018-4546-8","volume":"18","author":"L Zhao","year":"2018","unstructured":"Zhao L, Zhao H, Yan H (2018) Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes. BMC Cancer 18:603","journal-title":"BMC Cancer"},{"key":"20_CR108","first-page":"7398","volume":"14","author":"D Zhi","year":"2017","unstructured":"Zhi D, Zhao X, Dong M, Yan C (2017) miR-493 inhibits proliferation and invasion in pancreatic cancer cells and inversely regulated hERG1 expression. Oncol Lett 14:7398\u20137404","journal-title":"Oncol Lett"},{"key":"20_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.189","volume":"8","author":"S Zhu","year":"2017","unstructured":"Zhu S, Zhou HY, Deng SC, Deng SJ, He C, Li X, Chen JY, Jin Y, Hu ZL, Wang F et al (2017) ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca(2+)\/RhoA pathway. Cell Death Dis 8:e2806","journal-title":"Cell Death Dis"}],"container-title":["Reviews of Physiology, Biochemistry and Pharmacology","Transportome Malfunction in the Cancer Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/112_2020_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T02:04:30Z","timestamp":1649815470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/112_2020_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030909192","9783030909208"],"references-count":110,"URL":"https:\/\/doi.org\/10.1007\/112_2020_20","relation":{},"ISSN":["0303-4240","1617-5786"],"issn-type":[{"type":"print","value":"0303-4240"},{"type":"electronic","value":"1617-5786"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"9 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}